# ICSR-GENX:**GenAI-Powered Drug Safety Intelligence and ICSR Automation**

**ICSR-GENX** is a simulation project that automates key pharmacovigilance workflows using GenAI-style logic and rule-based Python modules. Inspired by Accenture‚Äôs SynOps platform, it showcases how independent innovators can replicate enterprise-grade ICSR processing ‚Äî including adverse event detection, MedDRA coding, and narrative generation ‚Äî using cost-free tools.


---

## üéØ Project Scope

This project simulates key components of Individual Case Safety Report (ICSR) processing using rule-based logic and GenAI-style automation. The following modules have been implemented:

- ‚úÖ **Case validation and triage**  
  Filters incoming ADR cases and flags serious ones based on predefined criteria.

- ‚úÖ **Serious adverse event detection**  
  Identifies and isolates cases marked as serious for priority handling.

- ‚úÖ **GenAI-based narrative generation**  
  Automatically generates human-like case summaries using structured data fields.

- ‚úÖ **Final case summary report generation**  
  Compiles processed cases into a structured output file for review or downstream use.

---

## üîÑ ICSR Workflow Overview

### üîπ Real-World ICSR Process (Simplified)

1. **Case Receipt** ‚Äì Intake of ADR data from structured or unstructured sources  
2. **Case Validation** ‚Äì Check for minimum criteria (patient, reporter, drug, event)  
3. **Case Triage** ‚Äì Classify cases as serious or non-serious  
4. **MedDRA Coding** ‚Äì Standardize event terms using MedDRA dictionary  
5. **Narrative Generation** ‚Äì Draft case summaries for regulatory review  
6. **Final Output** ‚Äì Export processed cases for downstream use or reporting

---

### üîπ What ICSR-GENX Implements

| Step               | Module             | Description |
|--------------------|--------------------|-------------|
| Case Receipt        | `raw_data.csv`      | Structured CSV input containing ADR case data |
| Case Triage         | `ae_detector.py`    | Flags serious cases based on seriousness criteria |
| MedDRA Coding       | `meddra_coder.py`   | Maps event terms to MedDRA Preferred Term and SOC |
| Narrative Generation| `narrative_gen.py`  | Generates GenAI-style summaries from structured fields |
| Final Output        | `narrative_cases.csv` | Consolidated output with enriched case data |

---

## üìù Example Narrative Output

Below is a sample GenAI-style narrative generated by the `narrative_gen.py` module from structured ICSR data:

> **Case ID**: ICSR001  
> **Drug Name**: Metformin  
> **Narrative**: A 65-year-old male patient from India reported hypoglycaemia following administration of Metformin.  
> The case was classified as serious and the outcome was recovered.

This output is part of the `narrative_cases.csv` file located in the `/outputs` folder.  
Each narrative is automatically constructed using patient demographics, drug-event relationships, seriousness classification, and outcome status.

---

## üõ†Ô∏è Tech Stack

| Tool / Library     | Purpose                                                  |
|--------------------|----------------------------------------------------------|
| **Python**         | Core scripting language for all modules                  |
| **Pandas**         | Data manipulation, filtering, and CSV processing         |
| **CSV files**      | Input/output format for ICSR case data and MedDRA mapping|
| **OS module**      | Handles file paths and output directory creation         |
| **Google Colab / CLI** | Execution environment for running and testing scripts |

---

## üìÅ Folder Structure

---

## üì£ Why This Project?

Accenture‚Äôs SynOps platform reduced PV report timelines from 50+ days to under a minute using GenAI. ICSR-GENX shows how similar intelligence can be simulated independently ‚Äî without paid APIs or cloud infrastructure.

This project is ideal for:
- Pharmacovigilance and Clinical data management role job seekers
- Recruiters evaluating GenAI readiness
- Academic publishing and portfolio building

---

## üìé License

MIT ‚Äì Free to use, adapt, and build upon.

---

## üìÇ Data Sources

Data used in this project was derived from publicly accessible pharmacovigilance databases, including:

- [WHO VigiAccess](https://vigiaccess.org/)
- [FDA FAERS](https://www.fda.gov/drugs/questions-and-answers-fdas-adverse-event-reporting-system-faers/fda-adverse-event-reporting-system-faers)
- [EU ADR Reports](https://www.adrreports.eu/)
- [OpenVigil](https://openvigil.sourceforge.net/)
- [Canada Vigilance](https://health-products.canada.ca/adverse-reaction-monitoring/index-eng.jsp)
- [Japan PMDA](https://www.pmda.go.jp/english/safety/info-services/adr-info/0001.html)
- [Australia DAEN](https://www.tga.gov.au/database-adverse-event-notifications-daen)
- [SIDER](http://sideeffects.embl.de/)
- [OpenFDA API](https://open.fda.gov/apis/)

> ‚ö†Ô∏è *Note: This project does not extract or process real patient data. All datasets used are simulated and anonymized for educational and demonstration purposes only. Data structures are inspired by publicly available pharmacovigilance portals.*

---

## üìö References

- Accenture. (2023). *SynOps for Pharmacovigilance: Transforming Drug Safety with GenAI*. [Accenture PV SynOps Overview](https://www.accenture.com/us-en/services/life-sciences/synops-pharmacovigilance)
- U.S. FDA. *Postmarketing Safety Reporting Requirements for Human Drug and Biological Products*. [FDA Guidance](https://www.fda.gov/media/78504/download)
- WHO. (2002). *Safety Monitoring of Medicinal Products: Guidelines for Setting Up and Running a Pharmacovigilance Centre*. [WHO PV Manual](https://apps.who.int/iris/handle/10665/42493)
- Naranjo CA et al. (1981). *A method for estimating the probability of adverse drug reactions*. Clin Pharmacol Ther. [PubMed Link](https://pubmed.ncbi.nlm.nih.gov/7249508/)
- EMA. *EudraVigilance and ICSR Reporting Requirements*. [EMA Guidance](https://www.ema.europa.eu/en/human-regulatory/research-development/pharmacovigilance/eudravigilance)
